Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.86 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.82 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.73 |
| ▸ | RARB | P10826 | 3/20 | 0.69 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.65 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.62 |
| ▸ | THRA | P10827 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3968275 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2039230 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2354201 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL15177361 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10497781 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10499017 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL762326 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10497130 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2035476 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL498865 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417360-A | Fluorescent compound, preparation method thereof and application thereof in preparation of fluorescent chiral liquid crystal film | 苏州欧德丽尔新材料科技有限公司 | 2024-01-19 | — | — | CN | disclosed |
| US-9074129-B2 | Mechanochromic luminescent difluoroboron beta-diketonates | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-20140073558-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CUBIST PHARMACEUTICALS, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-20130210053-A1 | MECHANOCHROMIC LUMINESCENT DIFLUOROBORON BETA-DIKETONATES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2013-08-15 | — | — | US | disclosed |
| US-8507647-B2 | Antibacterial agents for the treatment of gram positive infections | CUBIST PHARMACEUTICALS, INC. (US) | 2013-08-13 | — | — | US | disclosed |
| WO-2011068537-A2 | MECHANOCHROMIC LUMINESCENT DIFLUOROBORON BETA-DIKETONATES | FRASER CASSANDRA L (US) | 2011-06-09 | — | — | WO | disclosed |
| US-7898625-B2 | Liquid crystal device having a pair of electrodes with a vertical alignment film in which the chiral pitch length to gap ratio (P/G) is 0.06 to less than 1.0 | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7736533-B2 | Liquid crystal composition, liquid crystal device, reflective display material and light modulating material | FUJIFILM CORPORATION (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20100039595-A1 | LIQUID CRYSTAL DEVICE | FUJIFILM CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| US-7566737-B2 | Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2009-07-28 | — | — | US | disclosed |
| US-20090098314-A1 | Liquid crystal composition, liquid crystal device, reflective display material and light modulating material | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20070032543-A1 | Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients | GENFIT (FR) | 2007-02-08 | — | — | US | disclosed |
| EP-0296793-B1 | COLOUR PHOTOGRAPHIC SILVER HALIDE MATERIALS AND PROCESS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1993-08-25 | — | — | EP | disclosed |
| EP-0328669-A1 | CHALCONE DERIVATIVE COMPOUNDS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0296793-A2 | Colour photographic silver halide materials and process | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-12-28 | — | — | EP | disclosed |
| US-4192895-A | SUBSTITUTED BENZALDEHYDES AND PHENYL ALKYL KETONES | RICHARDSON-MERRELL INC. (US) | 1980-03-11 | — | — | US | disclosed |
| US-4122191-A | SUBSTITUTED BENZALDEHYDES OR PHENYL ALKYL KETONES | RICHARDSON-MERRELL INC. (US) | 1978-10-24 | — | — | US | disclosed |
| US-4057530-A | STABILIZERS FOR VINYL CHLORIDE POLYMERS | LABAZ (FR) | 1977-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032543-A1 | Combinations of substituted 1,3-diphenylprop-2-EN-1-one derivatives with other therapeutically active ingredients | PSEN1, BACE1, PSEN2 | GAA 310/4885L3MBTL1 3034/4885TP53 762/4885 |
| US-20140073558-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CLPP, CLPTM1, RPN1 | GAA 979/4885L3MBTL1 1585/4885TP53 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.